Your browser doesn't support javascript.
loading
Unraveling genetic predisposition to familial or early onset gastric cancer using germline whole-exome sequencing.
Vogelaar, Ingrid P; van der Post, Rachel S; van Krieken, J Han Jm; Spruijt, Liesbeth; van Zelst-Stams, Wendy Ag; Kets, C Marleen; Lubinski, Jan; Jakubowska, Anna; Teodorczyk, Urszula; Aalfs, Cora M; van Hest, Liselotte P; Pinheiro, Hugo; Oliveira, Carla; Jhangiani, Shalini N; Muzny, Donna M; Gibbs, Richard A; Lupski, James R; de Ligt, Joep; Vissers, Lisenka E L M; Hoischen, Alexander; Gilissen, Christian; van de Vorst, Maartje; Goeman, Jelle J; Schackert, Hans K; Ranzani, Guglielmina N; Molinaro, Valeria; Gómez García, Encarna B; Hes, Frederik J; Holinski-Feder, Elke; Genuardi, Maurizio; Ausems, Margreet G E M; Sijmons, Rolf H; Wagner, Anja; van der Kolk, Lizet E; Bjørnevoll, Inga; Høberg-Vetti, Hildegunn; van Kessel, Ad Geurts; Kuiper, Roland P; Ligtenberg, Marjolijn J L; Hoogerbrugge, Nicoline.
Afiliação
  • Vogelaar IP; Department of Human Genetics, Radboud university medical center, Nijmegen, The Netherlands.
  • van der Post RS; Department of Pathology, Radboud university medical center, Nijmegen, The Netherlands.
  • van Krieken JHJ; Department of Pathology, Radboud university medical center, Nijmegen, The Netherlands.
  • Spruijt L; Department of Human Genetics, Radboud university medical center, Nijmegen, The Netherlands.
  • van Zelst-Stams WA; Department of Human Genetics, Radboud university medical center, Nijmegen, The Netherlands.
  • Kets CM; Department of Human Genetics, Radboud university medical center, Nijmegen, The Netherlands.
  • Lubinski J; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
  • Jakubowska A; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
  • Teodorczyk U; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
  • Aalfs CM; Department of Clinical Genetics, Academic Medical Centre, Amsterdam, The Netherlands.
  • van Hest LP; Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands.
  • Pinheiro H; Expression Regulation in Cancer Group, Instituto de Investigação e Inovação em Saúde, Porto, Portugal.
  • Oliveira C; Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal.
  • Jhangiani SN; Expression Regulation in Cancer Group, Instituto de Investigação e Inovação em Saúde, Porto, Portugal.
  • Muzny DM; Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal.
  • Gibbs RA; Department of Pathology and Oncology, Faculty of Medicine, University of Porto, Al Prof Hernâni Monteiro, Porto, Portugal.
  • Lupski JR; Human Genome Sequencing Center, Baylor College of Medicine, One Baylor Plaza, Houston, TX, USA.
  • de Ligt J; Department of Molecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza, Houston, TX, USA.
  • Vissers LELM; Human Genome Sequencing Center, Baylor College of Medicine, One Baylor Plaza, Houston, TX, USA.
  • Hoischen A; Department of Molecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza, Houston, TX, USA.
  • Gilissen C; Human Genome Sequencing Center, Baylor College of Medicine, One Baylor Plaza, Houston, TX, USA.
  • van de Vorst M; Department of Molecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza, Houston, TX, USA.
  • Goeman JJ; Human Genome Sequencing Center, Baylor College of Medicine, One Baylor Plaza, Houston, TX, USA.
  • Schackert HK; Department of Molecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza, Houston, TX, USA.
  • Ranzani GN; Department of Human Genetics, Radboud university medical center, Nijmegen, The Netherlands.
  • Molinaro V; Department of Human Genetics, Radboud university medical center, Nijmegen, The Netherlands.
  • Gómez García EB; Department of Human Genetics, Radboud university medical center, Nijmegen, The Netherlands.
  • Hes FJ; Department of Human Genetics, Radboud university medical center, Nijmegen, The Netherlands.
  • Holinski-Feder E; Department of Human Genetics, Radboud university medical center, Nijmegen, The Netherlands.
  • Genuardi M; Department for Health Evidence, Radboud university medical center, Nijmegen, The Netherlands.
  • Ausems MGEM; Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, The Netherlands.
  • Sijmons RH; Department of Surgical Research, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Wagner A; Department of Biology and Biotechnology, University of Pavia, Pavia, Italy.
  • van der Kolk LE; Department of Biology and Biotechnology, University of Pavia, Pavia, Italy.
  • Bjørnevoll I; Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Høberg-Vetti H; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.
  • van Kessel AG; Medizinische Klinik und Poliklinik IV, Campus Innenstadt, Klinikum der Universität München, München, Germany.
  • Kuiper RP; Institute of Genomic Medicine, Catholic University of the Sacred Heart, Rome, Italy.
  • Ligtenberg MJL; Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Hoogerbrugge N; Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Eur J Hum Genet ; 25(11): 1246-1252, 2017 11.
Article em En | MEDLINE | ID: mdl-28875981
ABSTRACT
Recognition of individuals with a genetic predisposition to gastric cancer (GC) enables preventive measures. However, the underlying cause of genetic susceptibility to gastric cancer remains largely unexplained. We performed germline whole-exome sequencing on leukocyte DNA of 54 patients from 53 families with genetically unexplained diffuse-type and intestinal-type GC to identify novel GC-predisposing candidate genes. As young age at diagnosis and familial clustering are hallmarks of genetic tumor susceptibility, we selected patients that were diagnosed below the age of 35, patients from families with two cases of GC at or below age 60 and patients from families with three GC cases at or below age 70. All included individuals were tested negative for germline CDH1 mutations before or during the study. Variants that were possibly deleterious according to in silico predictions were filtered using several independent approaches that were based on gene function and gene mutation burden in controls. Despite a rigorous search, no obvious candidate GC predisposition genes were identified. This negative result stresses the importance of future research studies in large, homogeneous cohorts.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Testes Genéticos / Mutação em Linhagem Germinativa / Predisposição Genética para Doença / Exoma Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Hum Genet Assunto da revista: GENETICA MEDICA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Holanda País de publicação: ENGLAND / ESCOCIA / GB / GREAT BRITAIN / INGLATERRA / REINO UNIDO / SCOTLAND / UK / UNITED KINGDOM

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Testes Genéticos / Mutação em Linhagem Germinativa / Predisposição Genética para Doença / Exoma Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Hum Genet Assunto da revista: GENETICA MEDICA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Holanda País de publicação: ENGLAND / ESCOCIA / GB / GREAT BRITAIN / INGLATERRA / REINO UNIDO / SCOTLAND / UK / UNITED KINGDOM